Theratechnologies' Ibalizumab Study: A Potential Game-Changer for Multidrug-Resistant HIV
|
It is used in combination with other antiretrovirals to
treat heavily treatment-experienced adults with multidrug-resistant HIV-1
infection. Study ... |
amfAR Awards Boost Aspiring HIV Researchers
While antiretroviral therapy stops HIV from replicating, it cannot eradicate the hidden reservoir of dormant virus, the main barrier to a cure. View article...